Drug Development Technology Company Profile

00:41 EDT 19th March 2018 | BioPortfolio

Established in 1972, SPG Media PLC is an international business-to-business media company providing world-class controlled circulation magazines, internet reference portals, business conferences and forums.
Our extensive expertise, built through a long history in publishing, has led to an impressive array of products. Our well-respected websites have established themselves as leading sources of information within the industries they serve while our print publications feature editorial content designed to present and analyse cutting edge technology and strategies.
Our mission is to provide senior executives, decision-makers and business communities throughout the world with valued information and services, by communicating industry developments, offering informed opinion and promoting our customers' products and servises


Brunel House55-57 North Wharf Road
W2 1LA
United Kingdom


Phone: 44 207 915 9957
Fax: 44 207 915 9958

News Articles [3093 Associated News Articles listed on BioPortfolio]

Otsuka to advance clinical development of anti-TB drug

Japan-based healthcare firm Otsuka Pharmaceutical has secured funding from the Bill & Melinda Gates Foundation to accelerate clinical development of...Read More... The post Otsuka to advance clini...

KAIST team develops technology to find optimum drug target for cancer

(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the o...

New Australian grant to support rare cancer drug development

Australia Health Minister Greg Hunt has announced new funding to support various organisations in the clinical development of new drugs...Read More... The post New Australian grant to support rare can...

Revived Leukemia drug follows a historical development path in three stages

Over the course of 2017, the acute myeloid leukemia (AML) market has experienced dramatic changes with the approval of various...Read More... The post Revived Leukemia drug follows a historical develo...

Cancer Research Technology: Driving Cancer Drug Development

In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship bet...

Catalent Biologics To Collaborate On Antibody-Drug Conjugate Development

NewsCatalent and Vaccinex, Inc., a clinical-stage biotechnology company, have agreed to develop an antibody-drug conjugate using Catalent’s proprietary SMARTag conjugation platform and GPEx cell lin...

Sanofi CMO offers window on ways pharma is integrating tech into drug development

Sanofi Chief Medical Officer Dr. Ameet Nathwani expressed excitement about the technology developments that stand to benefit drug development in a fireside chat at StartUp Health

Leukaemia drug may be repurposed to fight other cancers

New research from Arizona State University’s (ASU) Biodesign Institute has found that leukaemia drug ibrutinib, marketed by Janssen under the...Read More... The post Leukaemia drug may be repurposed...

PubMed Articles [4628 Associated PubMed Articles listed on BioPortfolio]

Integration of Antibody Array Technology into Drug Discovery and Development.

Antibody arrays represent a high-throughput technique that enables the parallel detection of multiple proteins with minimal sample volume requirements. In recent years, antibody arrays have been widel...


In the last few years there has been a huge progress in a development of printing techniques and their application in pharmaceutical sciences and particularly in the pharmaceutical technology. The var...

Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.

Understanding the drug development pathway is critical for streamlining the development of effective cancer treatments. The objective of the current study was to delineate the drug development timelin...

Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles-A Platform for Drug Development.

Mesoporous silica nanoparticles (MSNs) have shown great potential in improving drug delivery of poorly water soluble (BCS class II, IV) and poorly permeable (BCS class III, IV) drugs, as well as facil...

Microfluidics technology for drug delivery: A review.

Microfluidics is undoubtedly an influential technology that is currently revolutionizing the chemical and biological studies by replicating laboratory bench-top technology on a miniature chip-scale de...

Clinical Trials [4878 Associated Clinical Trials listed on BioPortfolio]

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Imaging the Neurochemistry of Drug Addiction With PET

Our project has two overarching goals. 1) We will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse includi...

Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

Background: Drug resistant tuberculosis is a serious public health problem that threatens the health of human life and the development of society and economy. At present, the diagnosis of...

Development of a Screening Strategy for Community-Based Adverse Drug Related Events in the Emergency Department

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting ...

Companies [4385 Associated Companies listed on BioPortfolio]

Receptron Incorporated

Receptron has a novel and proprietary position in drug discovery and development. The company's original focus was on diabetes but now has expanded to include a diverse portfolio of research and devel...

Locum International

The Locum International Group is a limited Research Association comprising of :(a.) A Pharmaceutical Research and Development Company with extensive experience in product development, manufacturing, r...

TransPharma Medical Ltd

stablished in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug del...

Anchor Therapeutics, Inc.

Anchor Therapeutics, Inc. is a leader in the development of pepducin technology. The Company is engaged in the licensing of pepducin technology as research tools for drug developm...

Penwest Pharmaceuticals

Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting i...

More Information about "Drug Development Technology" on BioPortfolio

We have published hundreds of Drug Development Technology news stories on BioPortfolio along with dozens of Drug Development Technology Clinical Trials and PubMed Articles about Drug Development Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drug Development Technology Companies in our database. You can also find out about relevant Drug Development Technology Drugs and Medications on this site too.

Quick Search


Relevant Topic

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record